Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | -.--% | +240.87% |
Financials (USD)
Sales 2024 * | 17.7M | Sales 2025 * | 20.32M | Capitalization | 4.46B |
---|---|---|---|---|---|
Net income 2024 * | -97M | Net income 2025 * | -115M | EV / Sales 2024 * | 231 x |
Net cash position 2024 * | 376M | Net cash position 2025 * | 302M | EV / Sales 2025 * | 204 x |
P/E ratio 2024 * |
-48.1
x | P/E ratio 2025 * |
-36.8
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
1 month | +0.59% | ||
3 months | +84.47% | ||
6 months | +319.16% | ||
Current year | +240.87% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.86% | - |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ALPN Stock